Meticrane - Sodium Channel 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
Meticrane - Sodium Channel 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
Meticrane - Sodium Channel 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMeticraneCat. No.: HY-B0908CAS No.: 1084-65-7分式: CHNOS分量: 275.34作靶点: Sodium Channel; Chloride Channel作通路: Membrane Transporter/Ion Channel储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 50

2、mg/mL (181.59 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (9.08 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (9.08 mM); Clear solution1/2 Master of Small Molecules 您边的抑制剂师www.MedChemE3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 m

3、g/mL (9.08 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Meticrane种利尿剂。Meticrane 抑制远曲管中钠离和氯离的重 吸收。Meticrane 可于治疗原发性压。IC50 & Target Sodium and chloride ion 1体内研究 Meticrane, a thiazide diuretic is highly ranked in the connectivity map (cMap) analysis, and it does not haveany known anti-cancer or immune-st

4、imulating effect. Co-treatment with Meticrane significantly enhancestreatment efficacy of CTLA-4 blockade 2.PROTOCOLAnimal Mice 2Administration 2 Meticrane is dissolved in DMSO to a concentration of 160mg/mL. BALB/c (H-2d) mice receive daily i.p.injections at a dose of 400mg/kg bodyweight for 10 day

5、s post anti-CTLA4 treatment. The thiazide diureticMeticrane is used at doses of 150-300mg once daily; the reported LD50 for mice is 10g/kg after i.p.administration. 3 groups of standard BALB/c mice are treated consecutively (n=3/group) with increasingdoses of Meticrane i.p. (100mg/kg; 200mg/kg and 4

6、00mg/kg) for 10 days and monitored weight and generalwellbeing.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Rumiko TANAKA, et al. Crystal Structure of Meticrane. ANALYTICAL SCIENCES 2007, VOL. 23.2. Lesterhuis WJ, et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergisticdrug combinations. SciRep. 2015 Jul 21;5:12298.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.T

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论